Allianz Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,321
Closed -$354K 2661
2021
Q2
$354K Buy
3,321
+1
+0% +$119 ﹤0.01% 2204
2021
Q1
$506K Buy
+3,320
New +$540K ﹤0.01% 1896
2020
Q2
Sell
-3,477
Closed -$649K 2572
2020
Q1
$649K Buy
3,477
+1,280
+58% +$301K ﹤0.01% 1958
2019
Q4
$531K Buy
+2,197
New +$424K ﹤0.01% 2413

Other funds holding TECX

Allianz Asset Management's TECX Position: Q3 2021 in Review

Allianz Asset Management sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 3,321 shares — an estimated $354K sold.

Allianz Asset Management first reported a position in TECX in Q4 2019 and held it in 4 quarters. The position peaked at $649K in Q1 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Allianz Asset Management reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Allianz Asset Management sold 3,321 Tectonic Therapeutic shares in Q3 2021, an estimated $354K.
  • Allianz Asset Management first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 4 quarters.
  • Allianz Asset Management's Tectonic Therapeutic position peaked at $649K in Q1 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.